Sr. Manager, Biospecimen Management at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Deep knowledge of clinical biospecimen procedures and lifecycle including collection and tracking procedures, logistics considerations, chain of custody, issue escalation/resolution
Ability to work independently as an independent contributor with minimal to no supervision
Advanced working knowledge of compound and study related biospecimen requirements
Ability to seek knowledge beyond own area of specialty
Proficiency in creating biospecimen trackers using tools such as MS Excel, Spotfire, Tableau, or Polaris with minimal support
Ability to perform routine vendor management responsibilities, including requesting/accessing vendor/system inventory files and performing specimen tracking with minimal data integration
Ability to independently review clinical study protocols, compare with vendor statement of work, and provide feedback on biospecimen relevant sections
Ability to identify biospecimen related risks using risk library or de novo with support
Ability to exercise judgment within policy and procedure boundaries, troubleshoot routine problems, and provide mitigation proposals
Ability to prioritize activities during critical deadlines with little or no supervision

Responsibilities

Oversee and manage the complete lifecycle of biospecimens (collection, storage, use, and final disposition) for clinical studies with minimal to no supervision
Serve as core Clinical Team member responsible for creating the Specimen Management Plan and facilitating discussions to operationalize strategy
Provide shipping/sample movement and management, including requests, query and inventory reports, follow up on active issues with vendors, prepare sample management related reports, review/prepare tracking activities (e.g., vendor manifests/inventories, tissue/blood match pairing, depleted/non-viable samples, loading documents to Shared Drive folders)
Develop and implement biospecimen management plans for BMS-sponsored Phase 1-4 clinical trials and externally acquired biospecimens
Develop and execute asset and protocol-level biospecimen strategies
Work across the organization and with BMS’s partners to implement and project manage biospecimen strategies
Provide innovative solutions to oversee timelines for specimen data delivery to enable quick decision-making
Support biospecimen management for assets and contribute to optimizing cross-functional work streams related to biospecimens
Manage Critical to Quality (C2Q) processes with clinical teams
Identify and resolve vendor related issues in addition to vendor management responsibilities

Skills

Biospecimen Management

Clinical Trials

Project Management

Lifecycle Management

Specimen Collection

Specimen Storage

Cross-Functional Collaboration

Strategic Planning

Phase 1-4 Studies

Data Delivery

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free